Clinical Trials Logo

Clinical Trial Summary

This study evaluated the safety and efficacy of SPH4336 in combination with endocrine therapy in breast cancer Patients with brain metastases.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05872347
Study type Interventional
Source Shanghai Pharmaceuticals Holding Co., Ltd
Contact Shusen Wang
Phone 0086-020-87343811
Email wangshs@sysucc.org.cn
Status Recruiting
Phase Phase 2
Start date September 19, 2023
Completion date December 31, 2025